Physician utilization, risk-factor control, and CKD progression among participants in the Kidney Early Evaluation Program (KEEP). - Wikidata - wikimedia - TriplyDB

Physician utilization, risk-factor control, and CKD progression among participants in the Kidney Early Evaluation Program (KEEP).

Physician utilization, risk-factor control, and CKD progression among participants in the Kidney Early Evaluation Program (KEEP).

http://www.wikidata.org/entity/Q36845662

about

Multicenter epidemiological study to assess the population of CKD patients in Greece: results from the PRESTAR study Socioeconomic disparities in chronic kidney disease Raising awareness of acute kidney injury: a global perspective of a silent killer Advances in CKD detection and determination of prognosis: executive summary of the National Kidney Foundation-Kidney Early Evaluation Program (KEEP) 2012 annual data report.National Kidney Foundation's Kidney Early Evaluation Program (KEEP) annual data report 2011: executive summary Cardiovascular risk and mortality in end-stage renal disease patients undergoing dialysis: sleep study, pulmonary function, respiratory mechanics, upper airway collapsibility, autonomic nervous activity, depression, anxiety, stress and quality of li A systematic review of sleep disorders in patients with chronic kidney disease undergoing hemodialysis Association between lack of health insurance and risk of death and ESRD: results from the Kidney Early Evaluation Program (KEEP).Provision of care for chronic kidney disease by non-nephrologists in a developing nation: a national survey.Pharmacist-driven renal medication dosing intervention in a primary care patient-centered medical home.The self-management experience of patients with type 2 diabetes and chronic kidney disease: A qualitative study.

P2860

Q21131891-37F1209B-85AF-444E-ACE3-90B682B74B54 Q26991562-769FAD4E-61B0-4247-8FE9-AA6DF9F3B143 Q27025257-68A6392A-E8CB-4A45-BF53-8A76B24CDD10 Q30603143-390FDA73-D254-4DAA-9B73-64756C8B4C6B Q34160437-F825D751-FA18-4CEA-9D58-3771A74B9C6A Q35011252-8ABEB3DC-0EA3-45CA-8B5A-1BDB7B715C19 Q36100914-B0C6BE27-1CA0-4F1C-B7E8-417C64AA5F97 Q37083984-8CFC68D4-846A-45EE-BAAD-06E76119AFFD Q37177564-EC9E552B-71CB-4CF7-BEDF-A10A246015BB Q38262871-64EB699F-4BF6-4DA3-8FCD-F54917F811D4 Q38946115-2279C5CD-8F6A-4007-BC56-679D06E5E79B

P2860

Physician utilization, risk-factor control, and CKD progression among participants in the Kidney Early Evaluation Program (KEEP).

http://www.wikidata.org/entity/Q36845662

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Physician utilization, risk-fa ...... rly Evaluation Program (KEEP).

@en

type

label

Physician utilization, risk-fa ...... rly Evaluation Program (KEEP).

@en

prefLabel

Physician utilization, risk-fa ...... rly Evaluation Program (KEEP).

@en

P1433

Q36845662-9930B153-E75B-4DD9-96AC-3EA8FC11C9DA

P1476

Q36845662-BBA92BAA-17F5-4CEA-85C3-41A82D3D032F

P2093

Q36845662-231A9FE1-0781-4B82-B560-92B1D2B0A4E7

Q36845662-37748C40-DE10-4782-8E6F-9C4490A18ED9

Q36845662-3AA92EDB-CED0-42BE-AAD5-7BC30FA69C59

Q36845662-4089521D-488F-4A1B-83CC-87C1A624E1C2

Q36845662-458E1BDA-D1DE-494F-823C-D834A0B9E039

Q36845662-4B2A647F-6139-4A36-AC9F-9D959237BFED

Q36845662-85F642B0-9A0C-4033-9208-D5E41CA03F1D

Q36845662-9369387D-4384-4624-85F7-9019011B5D7A

Q36845662-B3BA33A7-61F8-4412-B7A7-1ABFF33A94EA

Q36845662-FCA246C4-0F1F-409D-BE62-FF89E4A77E9B

P2860

Q36845662-110143A1-788C-43D3-879A-F9D9BD981A5B

Q36845662-1778CDBA-A454-4D62-B9A6-FA125CACDA10

Q36845662-3C487FEA-F926-494C-95ED-56EEAB4F6309

Q36845662-50446E8C-3D25-4A43-A0AB-5BE26E02A7FE

Q36845662-531C6568-5552-4306-B3E8-E4B9EDC99964

Q36845662-633B638A-766A-4395-B708-18FCD2D0ED2E

Q36845662-6933F4F7-B71B-42E4-8192-300EFF53F855

Q36845662-6A44C826-E3BD-4460-BFA5-CD78FECDC639

Q36845662-77633362-64B0-436A-8E97-86D62107B54B

Q36845662-82226BAE-8051-40C5-9C32-9691F806112C

P304

Q36845662-AF280EFB-C42F-4F6C-9438-59134A09659D

P31

Q36845662-60720CA1-0039-4051-8525-35595B60CB45

P356

Q36845662-9F46660B-ABEC-4661-AD95-1D3FF40D1971

P433

Q36845662-D93422CF-62C3-40C9-8FAA-E771600506C1

P478

Q36845662-35BB8259-BF05-4EAA-9A82-30154D6EA66C

P577

Q36845662-CA5918C0-A43D-4BD1-8D9E-7AEE78599419

P5875

Q36845662-7161E5EC-99B9-45E6-A1B0-C7B25CAC1463

P698

Q36845662-024770D9-3E96-4954-8BF6-D31D3F7436BC

P921

Q36845662-00FED9C2-6ADE-48F1-BC06-D948F7AC4774

P932

Q36845662-C0306B4A-7911-4AAB-B76B-F377066457E8

P356

J.AJKD.2011.11.019

P1433

American Journal of Kidney Diseases

P1476

Physician utilization, risk-fa ...... rly Evaluation Program (KEEP).

@en

P2093

Adam T Whaley-Connell

http://www.w3.org/2001/XMLSchema#string

Andrew S Bomback

http://www.w3.org/2001/XMLSchema#string

Claudine T Jurkovitz

http://www.w3.org/2001/XMLSchema#string

Daniel Elliott

http://www.w3.org/2001/XMLSchema#string

Georges Saab

http://www.w3.org/2001/XMLSchema#string

KEEP Investigators

http://www.w3.org/2001/XMLSchema#string

Keith C Norris

http://www.w3.org/2001/XMLSchema#string

Peter A McCullough

http://www.w3.org/2001/XMLSchema#string

Shu-Cheng Chen

http://www.w3.org/2001/XMLSchema#string

Suying Li

http://www.w3.org/2001/XMLSchema#string

P2860

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

A new equation to estimate glomerular filtration rate

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

CKD surveillance using laboratory data from the population-based National Health and Nutrition Examination Survey (NHANES).

Excerpts from the US Renal Data System 2009 Annual Data Report.

Effect of lovastatin on primary prevention of cardiovascular events in mild CKD and kidney function loss: a post hoc analysis of the Air Force/Texas Coronary Atherosclerosis Prevention Study.

Statin-associated myopathy.

Primary care-specialist collaboration in the care of patients with chronic kidney disease.

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.

P304

S24-33

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.AJKD.2011.11.019

http://www.w3.org/2001/XMLSchema#string

P433

3 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221837517

http://www.w3.org/2001/XMLSchema#string

P698

22339899

http://www.w3.org/2001/XMLSchema#string

P921

P932

3654535

http://www.w3.org/2001/XMLSchema#string